Proteomic changes in LNCaP and LNCaP-AKR1C3 cells

Figshare 2026 Dataset Open access

Read full text
Authors: Jing Li
DOI: 10.6084/m9.figshare.31189081
Cited by: 0

Abstract

Radioresistance is one of the primary causes of prostate cancer treatment failure and post-radiotherapy progression. However, there is currently a lack of effective targets to increase radiotherapy sensitivity and inhibit malignant progression. We identified AKR1C3 as a potential key target associated with radioresistance and malignant progression. Here we explore the Proteomic changes in LNCaP and LNCaP-AKR1C3 cells.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Effects of Radiation Exposure Aldose Reductase and Taurine

Publication details

Journal / source
Figshare
Publication date
1 January 2026
Document type
Dataset